Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Novel Lipoprotein Properties Associated With an Increased Risk to Develop Atherosclerosis

NCT04487223 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT04487223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04487223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Novel Lipoprotein Properties Associated With an Increased Risk to Develop Atherosclerosis
Lead sponsor
Sheba Medical Center
Phase
Observational
Overall status
Unknown status
Start date
April 27, 2020
Completion date
April 27, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis